ICD-10 Specific code P25: Interstitial emphysema and related conditions originating in the perinatal period

Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.

Translations

Language Translation
Flag for English language  English Interstitial emphysema and related conditions originating in the perinatal period
Flag for French language  French Emphysème interstitiel et affections apparentées survenant pendant la période périnatale

Hierarchical position

Level Code Title
1 XVI Certain conditions originating in the perinatal period
2 P20-P29 Respiratory and cardiovascular disorders specific to the perinatal period
3 P25 Interstitial emphysema and related conditions originating in the perinatal period

Contents

Code Title
P25.0 Interstitial emphysema originating in the perinatal period
P25.1 Pneumothorax originating in the perinatal period
P25.2 Pneumomediastinum originating in the perinatal period
P25.3 Pneumopericardium originating in the perinatal period
P25.8 Other conditions related to interstitial emphysema originating in the perinatal period

Indicated medicines

Active Ingredient

Nintedanib is a triple angiokinase inhibitor blocking vascular endothelial growth factor receptors (VEGFR 1-3), platelet-derived growth factor receptors (PDGFR α and β) and fibroblast growth factor receptors (FGFR 1-3) kinase activity. Nintedanib binds competitively to the adenosine triphosphate (ATP) binding pocket of these receptors and blocks the intracellular signalling which is crucial for the proliferation and survival of endothelial as well as perivascular cells (pericytes and vascular smooth muscle cells).